Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Assess Safety and Biomarker Responses of the Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

NCT05076006 is registered in ClinicalTrials.gov with Emma Guttman as lead sponsor.

NCT NCT05076006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05076006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Assess Safety and Biomarker Responses of the Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia
Lead sponsor
Emma Guttman
Phase
Phase 2
Overall status
Completed
Start date
May 19, 2021
Completion date
September 30, 2023
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cicatricial alopecia